MedTrace Logo

Characterization of Local Vascular Effects of LNMMA

NCT00180063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2005-11-02

No results posted yet for this study

Summary

Characterization of an unexpected venodilative effect of higher L-NMMA-doses in dorsal human hand veins.

Conditions

  • Healthy Subjects

Interventions

DRUG

L-NMMA(drug)

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Wilhelm Kirch, MD · Institute of Clinical Pharmacology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-10-31
Completion
2005-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180063 on ClinicalTrials.gov